Results 281 to 290 of about 147,687 (343)
Analysis between Helicobacter pylori infection and hepatobiliary diseases. [PDF]
Yu Z +10 more
europepmc +1 more source
The comparative genomic analysis provides information about how C. tertium HGMC01 strain cause disease through mucin glycan degradation, colonization, multidrug resistance, and modulation of immune responses. Moreover, this analysis data suggest that this strain interacts with host cells by degrading mucin in the gut, potentially through recognition or
Seonghun Kim +2 more
wiley +1 more source
A scoping review of worldwide guidelines for diagnosis and treatment of Helicobacter pylori infection. [PDF]
Sun M, Liu E, Yang L, Cao H, Han M.
europepmc +1 more source
ABSTRACT With the global aging trend intensifying, cancer presents a significant health challenge for the elderly. This study aims to assess the prevalence, mortality, and disability‐adjusted life years (DALY) burden of cancer among individuals aged 60–94 worldwide from 1990 to 2021.
Xiaohan Zhu +4 more
wiley +1 more source
Asia-Pacific Survey on the Management of Helicobacter pylori Infection. [PDF]
Otani K +9 more
europepmc +1 more source
The phytochemical profile and biological activities of Cistus creticus leaf ethanolic extracts show strong seasonal variation. Spring extracts contain the highest phenolic levels with potent antioxidant and anti‐inflammatory effects, while summer extracts are richest in flavonoids and exhibit the greatest sun protection factor value and enzyme ...
Khalil Guelifet +11 more
wiley +1 more source
Relationship between the degree of Helicobacter pylori infection and miR-155 and miR-543 expression levels in gastric cancer. [PDF]
Wang Z, Zhou X, Yu M, Hu X.
europepmc +1 more source
Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma
This graphical abstract illustrates nanosystems used for targeted drug delivery into tuberculosis granulomas. It shows how targeting is influenced by size, pH, redox sensitivity, and surface charge. Various nanoparticles are incorporated with drugs to enhance penetration, stability, and release.
Shreya Ranjith Singh +3 more
wiley +1 more source
Tegoprazan as First- and Second-Line Therapy for Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. [PDF]
Purja S, Lee Y, Kim E.
europepmc +1 more source

